HopeStage
Back to all studies
CompletedNCT03892915

Depression Care and HIV Prevention During Pregnancy

About this title

Maternal Depression Treatment in HIV

Read the official source — NCT03892915
Interventional studyAges 18+Uganda
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
KampalaSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: July 8, 2019
Recruitment status
Completed
Enrollment listed in the registry
391
Sponsor
RAND
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
COMBINATION_PRODUCT
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Uganda
Age range
Over 18 Years
Official registry ID
NCT03892915
Official title
Show the full official title

Depression Care to Improve Adherence to Prevention of Mother-to-Child-Transmission (PMTCT) Care Continuum & Pregnancy Outcomes

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Kampala

FAQ

Questions about this study

Who is behind this study?

The study sponsor is RAND.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies